Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Policies need to address the growing threat of antimicrobial resistance

By Jocelyn Ulrich  |    April 28, 2023
Today, the House Energy & Commerce Subcommittee on Oversight and Investigations will be holding a hearing on the growing public health threat of antimicrobial resistance (AMR). AMR occurs when...   Read More

World IP Day 2023: Celebrating women leaders in innovation

By Megan Van Etten  |    April 26, 2023
Today PhRMA joins with innovators around the globe to recognize World IP Day and celebrate biopharmaceutical innovators who dedicate their lives to bringing new treatments and cures to patients. It’s...   Read More

Three facts about health care spending

By Sarah Ryan  |    April 25, 2023
There is increasing talk about making changes to our health care system to lower costs for patients and address misaligned incentives. These are important conversations that could lead to meaningful...   Read More

AHIP’s latest misinformation campaign & what it’s trying to hide

By Robert Zirkelbach  |    April 24, 2023
If we needed any more proof that the health insurance and pharmacy benefit manager (PBM) industries are one and the same, look no further than a new ad campaign by America’s Health Insurance Plans...   Read More

Nonprofit hospitals fall short on community benefit, studies show

By Gabby Migliara  |    April 24, 2023
Nonprofit hospitals are supposed to help provide access to crucial treatment and services in our most vulnerable communities. But recent research adds to the mountain of evidence showing nonprofit...   Read More

PhRMA Otorga Beca a la “Emerson Diversity Health Foundation”

By Lori Reilly  |    April 19, 2023
PhRMA ha otorgado una beca de 140.000 USD a la “Emerson Diversity Health Foundation” como parte de nuestro compromiso de enfrentar la desigualdad en la asistencia médica y aumentar la diversidad de...   Read More

PhRMA awards grant to Emerson Diversity Health Foundation

By Lori Reilly  |    April 19, 2023
PhRMA has awarded a $140,000 grant to the Emerson Diversity Health Foundation as part of our commitment to addressing health inequities and enhancing clinical trial diversity.     Read More

CMS guidance on IRA price setting process doubles down on bad policy

By Nicole Longo  |    April 14, 2023
As part of the implementation of the Inflation Reduction Act (IRA), the Centers for Medicare & Medicaid Services (CMS) issued draft guidance on the process for setting the price of medicines. The...   Read More

What they are saying: Experts reinforce that TRIPS waiver expansion is harmful and unnecessary

By Megan Van Etten  |    April 13, 2023
At the direction of the U.S. Trade Representative, the U.S. International Trade Commission (USTIC) is investigating the impact of a proposed waiver of intellectual property (IP) protections for...   Read More

A guide to MedPAC’s Part B vote today

By Nicole Longo  |    April 13, 2023
Today, the Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises Congress on issues related to the Medicare program, will vote on draft recommendations...   Read More

New global analysis shows patient access challenges around the world

By Richard Kane  |    April 12, 2023
Today PhRMA released a new report that analyzes the share of new medicines that are available in over 70 countries and how long patients wait to receive them. The Global Access to New Medicines...   Read More

FDA should remain the authority on the safety and effectiveness of medicines

By Jim Stansel  |    April 12, 2023
Recent district court rulings set an alarming precedent that calls into question the authority of the U.S. Food and Drug Administration (FDA) to determine the safety and effectiveness of new...   Read More

ICYMI: PhRMA President and CEO Stephen J. Ubl discusses patient affordability

By Emilie Signora  |    April 7, 2023
PhRMA president and CEO Stephen J. Ubl spoke recently at The Hill’s event, “Pathways to Patient Affordability.” He spotlighted patients’ affordability challenges, the unintended consequences we’re...   Read More

MedPAC proposal threatens access to medicines in Part B

By Nicole Longo  |    April 6, 2023
Next week, the Medicare Payment Advisory Commission (MedPAC) will vote on a number of policy proposals for changing Medicare Part B. One of the proposals would recommend that Congress adjust the...   Read More

States can support access to medicine as COVID-19 Public Health Emergency ends

By Scott LaGanga  |    April 5, 2023
The United States will soon reach an important milestone in the COVID-19 pandemic: the official end of the federal public health emergency (PHE). According to the U.S. Department of Health and Human...   Read More

CMS coverage policy is detrimental to Alzheimer’s patients

By Gabby Migliara  |    April 4, 2023
This week marks a somber anniversary for patients with Alzheimer’s. Last year, the Centers for Medicare & Medicaid Services (CMS) finalized a national coverage determination (NCD) that, for the first...   Read More

Arkansas puts patients first with new share the savings law

By Hannah Loiacono  |    April 4, 2023
Recently, Arkansas became the latest state to enact a law so that many patients aren’t paying more for their medicines than their insurance company or pharmacy benefit manager (PBM). The policy,...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates